Search research articles
Contact Us
Filters
Showing results (121-130 of 136) with videos related to
Page
of 14
Sort By:
Vaccine
|
May 1, 2014
Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes
Kirill Kalnin, Timothy Tibbitts, Yanhua Yan, et al.
Journal of Virology
|
March 29, 2013
Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine
Subhashini Jagu, Kihyuck Kwak, John T Schiller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2014
Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ
Ruey-Shyang Soong, Liwen Song, Janson Trieu, et al.
Cancer Cell
|
December 17, 2013
A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer
Ravi K Anchoori, Balasubramanyam Karanam, Shiwen Peng, et al.
Clinical and Vaccine Immunology : CVI
|
May 15, 2015
Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies
Joshua W Wang, Subhashini Jagu, Wai-Hong Wu, et al.
Journal of Biomedical Optics
|
January 12, 2010
Photonic approach to the selective inactivation of viruses with a near-infrared subpicosecond fiber laser
Kong-Thon Tsen, Shaw-Wei D Tsen, Q Fu, et al.
The American Journal of Surgical Pathology
|
September 5, 2014
GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility
Natalie Banet, Allen M Gown, Ie-Ming Shih, et al.
Obstetrics and Gynecology
|
December 2, 2014
Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer
Britt K Erickson, Isaac Kinde, Zachary C Dobbin, et al.
Plos One
|
September 10, 2021
Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors
Ravi K Anchoori, Logan George, Ssu-Hsueh Tseng, et al.
Mbio
|
October 4, 2023
Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojector
Shiwen Peng, Hsin-Fang Tu, Michelle Cheng, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 136) with videos related to
Sort By:
Page
of 14
Vaccine
|
May 1, 2014
Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes
Kirill Kalnin, Timothy Tibbitts, Yanhua Yan, et al.
Journal of Virology
|
March 29, 2013
Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine
Subhashini Jagu, Kihyuck Kwak, John T Schiller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2014
Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ
Ruey-Shyang Soong, Liwen Song, Janson Trieu, et al.
Cancer Cell
|
December 17, 2013
A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer
Ravi K Anchoori, Balasubramanyam Karanam, Shiwen Peng, et al.
Clinical and Vaccine Immunology : CVI
|
May 15, 2015
Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies
Joshua W Wang, Subhashini Jagu, Wai-Hong Wu, et al.
Journal of Biomedical Optics
|
January 12, 2010
Photonic approach to the selective inactivation of viruses with a near-infrared subpicosecond fiber laser
Kong-Thon Tsen, Shaw-Wei D Tsen, Q Fu, et al.
The American Journal of Surgical Pathology
|
September 5, 2014
GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility
Natalie Banet, Allen M Gown, Ie-Ming Shih, et al.
Obstetrics and Gynecology
|
December 2, 2014
Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer
Britt K Erickson, Isaac Kinde, Zachary C Dobbin, et al.
Plos One
|
September 10, 2021
Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors
Ravi K Anchoori, Logan George, Ssu-Hsueh Tseng, et al.
Mbio
|
October 4, 2023
Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojector
Shiwen Peng, Hsin-Fang Tu, Michelle Cheng, et al.
Page
of 14